OpenURL Connection Search

Select item for more details and to access through your institution.

Impact of treatment with dimethyl fumarate on sleep quality in patients with relapsing-remitting multiple sclerosis: A multicentre Italian wearable tracker study.
Published in:
Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2023, v. 9, n. 1, p. 1, doi. 10.1177/20552173221144229
By:
- Comi, Giancarlo;
- Leocani, Letizia;
- Ferini-Strambi, Luigi;
- Radaelli, Marta;
- Costa, Gloria D;
- Lanzillo, Roberta;
- Lus, Giacomo;
- Bianchi, Valentina;
- Traccis, Sebastiano;
- Capone, Fioravante;
- Grimaldi, Luigi M. E.;
- Salemi, Giuseppe;
- Cardillo, Alessandra;
- Zipoli, Valentina
Publication type:
Article
High fever in myelin oligodendrocyte glycoprotein-associated disorder (MOGAD): A diagnostic challenge.
Published in:
Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2023, v. 9, n. 1, p. 1, doi. 10.1177/20552173221148911
By:
- Azar, Chadi;
- Akiki, Grace;
- Haddad, Sara F;
- Kerbage, Anthony;
- Haddad, Fady;
- Macaron, Gabrielle
Publication type:
Article
Endocrine and multiple sclerosis outcomes in patients with autoimmune thyroid events in the alemtuzumab CARE-MS studies.
Published in:
Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2023, v. 9, n. 1, p. 1, doi. 10.1177/20552173221142741
By:
- Dayan, Colin M.;
- Lecumberri, Beatriz;
- Muller, Ilaria;
- Ganesananthan, Sashiananthan;
- Hunter, Samuel F.;
- Selmaj, Krzysztof W.;
- Hartung, Hans-Peter;
- Havrdova, Eva K.;
- LaGanke, Christopher C.;
- Ziemssen, Tjalf;
- Van Wijmeersch, Bart;
- Meuth, Sven G.;
- Margolin, David H.;
- Poole, Elizabeth M.;
- Baker, Darren P.;
- Senior, Peter A.
Publication type:
Article

Found: 3

Impact of treatment with dimethyl fumarate on sleep quality in patients with relapsing-remitting multiple sclerosis: A multicentre Italian wearable tracker study.

High fever in myelin oligodendrocyte glycoprotein-associated disorder (MOGAD): A diagnostic challenge.

Endocrine and multiple sclerosis outcomes in patients with autoimmune thyroid events in the alemtuzumab CARE-MS studies.